The growth hormone response to apomorphine at 4 days postpartum in women with a history of major depression.
We have examined the responsiveness of dopamine sensitive neurones in the postpartum period in woman with a history of major depression who are at high risk of experiencing a recurrence of illness in the postpartum period. Fourteen women were assessed at 36 weeks of pregnancy and during the 3 months following delivery, using the Schedule for Affective Disorders and Schizophrenia, including its change version. They were not depressed at initial assessment. Five of the 14 women went on to experience a postpartum relapse (2 major depressive disorder, 2 generalised anxiety disorder, 1 panic disorder). On the fourth day postpartum, i.e., before relapse, the growth hormone response to the dopamine agonist apomorphine was measured as an index of the functional state of hypothalamic dopamine D2 receptors. Women who subsequently relapsed had a significantly greater growth hormone response to apomorphine than those who remained well. This was particularly marked in women with anxiety/panic. The development of increased sensitivity of hypothalamic dopamine D2 receptors in the postpartum period appears to predict the onset of depressive and anxiety disorders.
Mc Ivor
R J
RJ
Dept. of Psychiatry, Institute of Psychiatry, London, UK.
Davies
R A
RA
Wieck
A
A
Marks
M N
MN
Brown
N
N
Campbell
I C
IC
Checkley
S A
SA
Kumar
R
R
D001008:Anxiety Disorders / Q000097:blood / Q000175:diagnosis / Q000523:psychology; D001058:Apomorphine; D019052:Depression, Postpartum / Q000097:blood / Q000175:diagnosis* / Q000523:psychology; D003866:Depressive Disorder / Q000097:blood / Q000175:diagnosis* / Q000523:psychology; D018491:Dopamine Agonists; D005260:Female; D019382:Human Growth Hormone / Q000097:blood*; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects / Q000503:physiopathology; D016584:Panic Disorder / Q000097:blood / Q000175:diagnosis / Q000523:psychology; D010555:Personality Inventory; D011247:Pregnancy; D017448:Receptors, Dopamine D2 / Q000502:physiology; D012008:Recurrence; D012307:Risk Factors
D018491:Dopamine Agonists; D017448:Receptors, Dopamine D2; D019382:Human Growth Hormone; D001058:Apomorphine